Diisopropylethylamine → HCID 73775264, compound

HRID 1052704Notes

Reaction equation

HRID 1052704 reaction equation
[NH2:1][C@H:2]([C:4]1[N:9]([C:10]2[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=2)[C:8](=[O:16])[C:7]2=[C:17]([CH3:20])[CH:18]=[CH:19][N:6]2[N:5]=1)[CH3:3].Cl[C:22]1[C:23]2[CH:31]=[CH:30][S:29][C:24]=2[N:25]=[C:26]([CH3:28])[N:27]=1.C(N(CC)C(C)C)(C)C>>[CH3:20][C:17]1[CH:18]=[CH:19][N:6]2[C:7]=1[C:8](=[O:16])[N:9]([C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1)[C:4]([C@@H:2]([NH:1][C:22]1[C:23]3[CH:31]=[CH:30][S:29][C:24]=3[N:25]=[C:26]([CH3:28])[N:27]=1)[CH3:3])=[N:5]2

Participants

4

Procedure

(S)-2-(1-Aminoethyl)-5-methyl-3-phenylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one (50 mg, 0.16 mmol) was treated with 4-chloro-2-methylthieno[2,3-d]pyrimidine (45 mg, 0.25 mmol), N,N-diisopropylethylamine (257 μl, 1.48 mmol) according to the method described in Example 17. The crude was purified using SP1® Purification System by reverse phase to give 27 mg (40% yield) of the title compound as a white solid. Purity 100%.

Workup

  1. customThe crude was purified
  2. customSP1® Purification System

Sources & evidence

ORD record
ord-fa130a5cdb464f94b309cab3a79409de
Source dataset
uspto-grants-2016_07
Patent number
US09388189B2

Reaction notes

Loading…